Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tropocollagen is the fundamental structural unit of collagen fibers. Newly formed tropocollagen cross-links refer to the covalent bonds that form between lysine and hydroxylysine residues on adjacent tropocollagen molecules during collagen maturation[1][3][4]. These enzymatically mediated covalent bonds stabilize the triple-helical structure and are essential for assembling strong, resilient collagen fibrils in connective tissues. The formation and density of these cross-links directly influence the mechanical properties—such as tensile strength and toughness—of tissues like skin, bone, cartilage, and tendons[2][4]. Abnormalities in this process can result in pathological conditions; insufficient cross-linking leads to weak connective tissue (as seen in Ehlers–Danlos syndrome), while excessive or nonenzymatic glycation-induced ("AGE") cross-links contribute to age-related stiffness and brittleness[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tropocollagen cross-link.